Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lymphedema × Drug Evaluation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 3 Breast Neoplasms 3 Lymphoma, Non-Hodgkin 2 Carcinoma, Basal Cell 2 Basal Cell Nevus Syndrome 2 Upper Tract Urothelial Carcinomas 1 Thrombocythemia, Essential 1 Solid Tumors 1 Serous Ovarian Cancer 1 Recurrence 1 Postmenopausal Women With ER+ HER2- Primary Breast Cancer 1 Polycythemia Vera 1 Lymphedema 1 Leukemia 1 Immunoglobulin Light-chain Amyloidosis 1 Hypogonadism 1 Glioma 1 Fatigue Syndrome, Chronic 1 Fallopian Tube Neoplasms 1 Eunuchism 1 Colorectal Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Diseases 1 Amyloidosis 1 Adenoma 1

Interventions

Exercise 10 Manual Lymphatic Drainage 9 Low-Level Light Therapy 5 Standard of Care 4 Physical Therapy Modalities 4 Acupuncture Therapy 4 Resistance Training 3 Methods 3 Indocyanine Green 3 Compression Bandages 3 Yoga 2 Technetium Tc 99m Sulfur Colloid 2 Radiotherapy 2 Pentoxifylline 2 Lipectomy 2 High-Energy Shock Waves 2 Exercise Therapy 2 Early Intervention, Educational 2 Control Groups 2 Bevacizumab 2 specific substance maruyama 1 pycnogenols 1 pirfenidone 1 pazopanib 1 carbohydrate-deficient transferrin 1 Wound Closure Techniques 1 Weights and Measures 1 Weight Reduction Programs 1 Vitamin E 1 Transplantation, Autologous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01893879 2017-05-18

PCTTPL

Stanford University

Phase NA Terminated

14 enrolled 5 charts

Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡